Eduardo Collantes Selected Research

Eduardo Collantes Research Topics

Disease

9	Ankylosing Spondylitis 11/2020 - 09/2007
6	Rheumatoid Arthritis 01/2021 - 05/2002
2	Arthritis (Polyarthritis) 10/2018 - 05/2002
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2018 - 10/2011
2	Uveitis 10/2018 - 09/2011
2	Joint Diseases (Joint Disease) 03/2010 - 01/2009
1	Atherosclerosis 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019
1	Disease Progression 01/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2018
1	Necrosis 09/2015
1	Back Pain (Backache) 11/2013
1	Axial Spondyloarthritis 11/2013
1	Sacroiliitis 11/2013
1	Spondylarthritis (Spinal Arthritis) 10/2011
1	Familial Mediterranean Fever (Periodic Disease) 07/2008
1	Inflammation (Inflammations) 07/2008
1	Localized Scleroderma (Morphea) 12/2006
1	Ulcer 12/2006
1	Hyperuricemia 05/2005
1	Hypertriglyceridemia 05/2005
1	Osteoarthritis 06/2004
1	Knee Osteoarthritis 06/2004
1	Erectile Dysfunction 08/2002
1	Gynecomastia 08/2002
1	Psoriatic Arthritis 08/2002

Drug/Important Bio-Agent (IBA)

7	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2020 - 04/2010
3	Pharmaceutical PreparationsIBA 01/2021 - 07/2015
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2008
2	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2008
2	C-Reactive ProteinIBA 10/2018 - 06/2011
2	AntigensIBA 05/2012 - 07/2008
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2011 - 05/2002
1	InflammasomesIBA 01/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	Cardiolipins (Cardiolipin)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Antiphospholipid AntibodiesIBA 01/2019
1	Thromboplastin (Tissue Factor)IBA 01/2019
1	Type II Tumor Necrosis Factor ReceptorsIBA 07/2015
1	HLA-DPA1 antigen (HLA DPA1)IBA 11/2011
1	HLA-DPB1 antigen (HLA DPB1)IBA 11/2011
1	Etanercept (Enbrel)FDA Link 10/2011
1	amsonic acid (DAS)IBA 03/2010
1	Indicators and Reagents (Reagents)IBA 03/2010
1	Peroxidase (Myeloperoxidase)IBA 01/2009
1	Infliximab (Remicade)FDA Link 01/2009
1	AutoantibodiesIBA 07/2008
1	Colchicine FDA LinkGeneric 07/2008
1	AA amyloidosisIBA 07/2008
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007
1	Endothelin Receptor AntagonistsIBA 12/2006
1	Bosentan (Tracleer)FDA Link 12/2006
1	Uric Acid (Urate)IBA 05/2005
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2005
1	Apolipoprotein C-IIIIBA 05/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2004
1	GlucocorticoidsIBA 06/2004
1	Methotrexate (Mexate)FDA LinkGeneric 08/2002
1	Antirheumatic Agents (DMARD)IBA 08/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2002
1	EtoricoxibIBA 05/2002

Therapy/Procedure

3	Therapeutics 06/2011 - 12/2006
1	Hip Prosthesis 09/2011